| 1 |
Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins |
|
| | Atsushi Hijikata, Clara Shionyu, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Tsuyoshi Shirai | | | Biophysics and Physicobiology. 2021; 18(0): 226 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates |
|
| | Sajad Fakhri,Zeinab Nouri,Seyed Zachariah Moradi,Esra Küpeli Akkol,Sana Piri,Eduardo Sobarzo-Sánchez,Mohammad Hosein Farzaei,Javier Echeverría | | | Molecules. 2021; 26(10): 2917 | | | [Pubmed] [Google Scholar] [DOI] | |
|
